Clinical Trial Update: Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on adaptive radiotherapy for non-small cell lung cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED